Adv. Prity Khastgir Delhi High Court IP Litigator (@SWOTLawyer) header
Adv. Prity Khastgir Delhi High Court IP Litigator (@SWOTLawyer) profile picture

Adv. Prity Khastgir Delhi High Court IP Litigator

@SWOTLawyer

🇮🇳 Protecting multi-million dollar ideas, one brief at a time. Brands built them, I defend them. Design, Patents, Trademarks, & Copyright 📍 New Delhi #IPRs

 New Delhi, India
linkedin.com/in/patentindiaiplawpritykhastgir/
Joined October 2026
  • Tweets5
  • Following1
  • Followers3
3Media
Photo by Adv. Prity Khastgir Delhi High Court IP Litigator (@SWOTLawyer)Photo by Adv. Prity Khastgir Delhi High Court IP Litigator (@SWOTLawyer)Photo by Adv. Prity Khastgir Delhi High Court IP Litigator (@SWOTLawyer)
💡 Strategic Business Playbook: How Innovator Pharma Survives the Patent Cliff #MarketMonopoly linkedin.com/pulse/strategic… 👇 #Pharmaceuticals #PatentCliff #IntellectualProperty #PharmaInnovation #Generics #HealthcareLaw #Ozempic #Biosimilars #ResearchAndDevelopment #IPR
💡 Strategic Business Playbook: How Innovator Pharma Survives the Patent Cliff #MarketMonopoly

💡 Strategic Business Playbook: How Innovator Pharma Survives the Patent Cliff #MarketMonopoly

In the pharmaceutical sector, the "Patent Cliff" the sudden drop in revenue when a blockbuster drug loses exclusivity is an inevitable commercial reality. https://www.

linkedin.com
9
#Pharmaceuticals #PatentCliff #IntellectualProperty #PharmaInnovation #Generics #HealthcareLaw #Ozempic #Biosimilars #ResearchAndDevelopment #IPR #IndianPharma #PharmaIndustry #DrugDiscovery #CorporateStrategy #HealthcareBusiness #LegalCompliance #MarketMonopoly #Innovation
7
Is this the end of painful weekly injections for millions of diabetes and weight-loss patients worldwide linkedin.com/pulse/end-painf… via @LinkedIn #GLP1 #Semaglutide #WeightLossPill #GenericDrugs #PharmaInnovation #HealthcareRevolution #Biotech #DiabetesCare #ObesityTreatment
Is this the end of painful weekly injections for millions of diabetes and weight-loss patients...

Is this the end of painful weekly injections for millions of diabetes and weight-loss patients...

A massive shake-up is brewing in the global pharmaceutical market, and it is happening right at the intersection of molecular engineering and intellectual property law. 🧑‍🔬 The Molecular Loophole:...

linkedin.com
1
1
9
Massive shake-up is brewing in the global pharmaceutical market, and it is happening right at the intersection of molecular engineering and intellectual property law #GLP1 #Semaglutide #WeightLossPill #GenericDrugs #PharmaInnovation #HealthcareRevolution #Biotech #DiabetesCare
🤖 Made with AI
#GLP1 #Semaglutide #WeightLossPill #GenericDrugs #PharmaInnovation #HealthcareRevolution #Biotech #DiabetesCare #ObesityTreatment #Cipla #SunPharma #Zydus #AffordableHealthcare #MedicalNews #PharmaLaw #HealthTech #FutureOfMedicine #MetabolicHealth #PharmaIndustry #IntellectualProperty #PatentLitigation

ALT #GLP1 #Semaglutide #WeightLossPill #GenericDrugs #PharmaInnovation #HealthcareRevolution #Biotech #DiabetesCare #ObesityTreatment #Cipla #SunPharma #Zydus #AffordableHealthcare #MedicalNews #PharmaLaw #HealthTech #FutureOfMedicine #MetabolicHealth #PharmaIndustry #IntellectualProperty #PatentLitigation

1
5
💊Oral GLP-1 Revolution Just Got a Major Boost in India A game-changing patent design-around could soon bring affordable, oral weight-loss and diabetes generic formulations to millions, entirely skipping the hassle of painful weekly injections #GLP1 #Semaglutide #WeightLossPill
1
9
Load more